Healthcare Distribution Alliance – Patients Move Us.
Share Print
banner capitol

Issues

Prescription Drug Abuse and Diversion

HDA and our primary pharmaceutical distributor members are committed to bringing industry and government together to tackle our nation’s complex prescription drug abuse and diversion epidemic, a serious healthcare challenge that threatens both patient safety and the security of the healthcare supply chain. While distributors do not prescribe or dispense drugs directly to patients, they do share a common goal with physicians, manufacturers, pharmacists, law enforcement officials and policymakers: to ensure a safe supply of medicines. Among other safeguards, distributors are dedicated to keeping prescription painkillers out of the hands of people who may use them for purposes other than those for which they are intended.

The resources below address the industry’s approach to countering diversion and ensuring the safe supply of medicines to licensed entities across the supply chain.

Resources

CONTACT

  • John E. Parker
  • Senior Vice President, Communications
  • (703) 885-0216
  • jparker@hda.org
  • Kristen L. Freitas
  • Vice President, Federal Government Affairs
  • (703) 885-0232
  • kfreitas@hda.org
  • Matthew J. DiLoreto
  • Vice President, State Government Affairs
  • (703) 885-0236
  • mdiloreto@hda.org
  • Ruth K. Miller
  • Senior Director, Regulatory Affairs
  • (703) 885-0266
  • rmiller@hda.org
  • Farah M. Simonett
  • Associate Director, Communications
  • (703) 885-0269
  • fsimonett@hda.org

The Vital Link in Healthcare

HDA's "Vital Link Toolkit" was created to inform and educate the public on the role of pharmaceutical distributors in the healthcare industry.

News

Read press releases, public testimony and executive statements about HDA's efforts on behalf of pharmaceutical distributors and the entire supply chain.

Website design and development by Americaneagle.com, inc
© 2017 Healthcare Distribution Alliance. All rights reserved.
HDA: M | C | D | NF | O365